Biotech

All Articles

Vaderis' rare capillary ailment medication lowers nosebleeds

.Vaderis Rehabs' goal to build the first drug aimed especially at a particular rare capillary proble...

Navigator increases $100M to develop brand new autoimmune pipeline

.Sat nav Medicines has outfitted itself with $one hundred million in collection A funds as the young...

Duality looks for money for ADC trials as IPO wave infects Asia

.China's Duality Biotherapeutics has filed (PDF) documentation for a Hong Kong IPO, looking for an u...

YolTech markets China legal rights to gene modifying treatment for $29M

.Four months after Mandarin gene editing firm YolTech Therapies took its cholesterol levels disease-...

Addex sell climbs after Indivior provides to $300M for material

.Indivior is getting a little particle allosteric modulator made to manage element use disorder comi...

Molecular Allies changes AML test over 'suboptimal exposure'

.Molecular Partners has recognized "suboptimal exposure" to its own tetra-specific T-cell engager as...

Despite combined market, an equity capital resurgence could be being available in Europe: PitchBook

.While the biotech financial investment scene in Europe has actually reduced somewhat complying with...

8 months after a $213M fundraise, genetics publisher Volume helps make cuts

.After rearing $213 million in 2023-- among the year's biggest personal biotech shots-- Volume Biosc...

BioMarin builds director group with biotech vets-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of significant leadership hirings, firings ...

Biopharma Q2 VC reached highest degree given that '22, while M&ampA slowed

.Equity capital backing right into biopharma cheered $9.2 billion throughout 215 sell the second fou...